Cargando…
Innovative Drugs to Target Renal Inflammation in Sepsis: Alkaline Phosphatase
Sepsis-related mortality roughly doubles when acute kidney injury (AKI) occurs and end-stage renal disease is more common in sepsis-associated AKI survivors. So far, no licensed treatment for the prevention of AKI is available, however the data on alkaline phosphatase (AP) is promising and might cha...
Autores principales: | Hümmeke-Oppers, Femke, Hemelaar, Pleun, Pickkers, Peter |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6716471/ https://www.ncbi.nlm.nih.gov/pubmed/31507417 http://dx.doi.org/10.3389/fphar.2019.00919 |
Ejemplares similares
-
Editorial: Innovative Biologics and Drugs to Target Renal Inflammation
por: Griffin, Matthew D., et al.
Publicado: (2020) -
Alkaline phosphatase treatment improves renal function in patients with severe sepsis or septic shock
por: Heemskerk, S, et al.
Publicado: (2007) -
Interaction of Serum Alkaline Phosphatase and Folic Acid Treatment on Chronic Kidney Disease Progression in Treated Hypertensive Adults
por: Zhang, Yuanyuan, et al.
Publicado: (2022) -
Pharmacokinetics, safety and tolerability of human recombinant alkaline phosphatase in healthy volunteers
por: Peters, E, et al.
Publicado: (2015) -
Alkaline phosphatase for treatment of sepsis-induced acute kidney injury: a prospective randomized double-blind placebo-controlled trial
por: Pickkers, Peter, et al.
Publicado: (2012)